Javascript must be enabled to continue!
Abstract 1510: Subtype-specific cancer driver gene detection improves sensitivity to detect drivers
View through CrossRef
Abstract
Identifying cancer driver mutations is a crucial step toward understanding the underlying mechanisms of oncogenesis. However, driver gene detection is complicated, considering the inherent complexity and heterogeneity of cancer.The past decade has seen the large-scale application of next-generation sequencing technologies (NGS) in cancer genomics, and many methods have been published utilizing NGS to detect novel oncogenic drivers. However, the low concordance across methods raises the concern about false positives and negatives in those findings. In particular, proper modeling of the background mutation profile (known to be affected by multiple factors) is critical to improving precision and recall in driver detection. Though intra-sample heterogeneity in the background mutation profile is considered to some extent in multiple methods, most computational driver detection methods assume a homogeneous mutational landscape across cancer samples. With more and more subtypes being discovered in various cancers, the assumption is largely untenable.
In this study, we present a driver gene detection framework taking into account the heterogeneous mutational context in a cancer cohort. Our approach improves sensitivity to detect drivers by first pre-selecting a more uniform sample subset to apply driver detection algorithms. We combine this method with enhancements to an existing ensemble approach that combines methods with different assumptions about the characteristics of driver mutations (recurrence across samples, functional impact bias and positional clustering). We apply this combined approach to ∼750 breast invasive carcinoma samples from The Cancer Genome Atlas. In this dataset, genes identified by our approach show higher enrichment in known cancer driver genes compared to other methods, and the subtype-driven method identifies additional potential drivers that are missing in overall analysis.
Citation Format: Yao Fu, Aparna Chhibber, Narges Bani-Asadi, Hugo YK Lam. Subtype-specific cancer driver gene detection improves sensitivity to detect drivers. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1510.
American Association for Cancer Research (AACR)
Title: Abstract 1510: Subtype-specific cancer driver gene detection improves sensitivity to detect drivers
Description:
Abstract
Identifying cancer driver mutations is a crucial step toward understanding the underlying mechanisms of oncogenesis.
However, driver gene detection is complicated, considering the inherent complexity and heterogeneity of cancer.
The past decade has seen the large-scale application of next-generation sequencing technologies (NGS) in cancer genomics, and many methods have been published utilizing NGS to detect novel oncogenic drivers.
However, the low concordance across methods raises the concern about false positives and negatives in those findings.
In particular, proper modeling of the background mutation profile (known to be affected by multiple factors) is critical to improving precision and recall in driver detection.
Though intra-sample heterogeneity in the background mutation profile is considered to some extent in multiple methods, most computational driver detection methods assume a homogeneous mutational landscape across cancer samples.
With more and more subtypes being discovered in various cancers, the assumption is largely untenable.
In this study, we present a driver gene detection framework taking into account the heterogeneous mutational context in a cancer cohort.
Our approach improves sensitivity to detect drivers by first pre-selecting a more uniform sample subset to apply driver detection algorithms.
We combine this method with enhancements to an existing ensemble approach that combines methods with different assumptions about the characteristics of driver mutations (recurrence across samples, functional impact bias and positional clustering).
We apply this combined approach to ∼750 breast invasive carcinoma samples from The Cancer Genome Atlas.
In this dataset, genes identified by our approach show higher enrichment in known cancer driver genes compared to other methods, and the subtype-driven method identifies additional potential drivers that are missing in overall analysis.
Citation Format: Yao Fu, Aparna Chhibber, Narges Bani-Asadi, Hugo YK Lam.
Subtype-specific cancer driver gene detection improves sensitivity to detect drivers.
[abstract].
In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA.
Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1510.
Related Results
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract
Introduction
Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
BRDriver: Breast Cancer Driver Gene Predictor
BRDriver: Breast Cancer Driver Gene Predictor
AbstractThe breast cancer mortality rate is high in developing countries as the early detection of cancer is deficient in patients. The identification of the genes that drive cance...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract
Aim: Epithelial ovarian cancer is one of the most lethal female cancers. It is a heterogeneous group of neoplasms and the different histologic subtypes are ...
Abstract 3958: Multi-Reg: An integrative parallel approach to uncover drivers of cancer
Abstract 3958: Multi-Reg: An integrative parallel approach to uncover drivers of cancer
Abstract
Tumor samples harbor a vast number of genomic alterations of various kinds, and it is difficult to distinguish driver alterations that contribute to oncogen...
Abstract 1910: Allelic imbalance for early detection of breast cancer in high depth whole genome sequencing
Abstract 1910: Allelic imbalance for early detection of breast cancer in high depth whole genome sequencing
Abstract
Liquid biopsy for circulating tumor DNA (ctDNA) offers potential for noninvasive early cancer detection. However, existing mutation- and methylation-based m...
Expression and polymorphism of genes in gallstones
Expression and polymorphism of genes in gallstones
ABSTRACT
Through the method of clinical case control study, to explore the expression and genetic polymorphism of KLF14 gene (rs4731702 and rs972283) and SR-B1 gene (rs...

